About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Ptp4a3tm1.1Geh
targeted mutation 1.1, Gregg E Homanics
MGI:5473867
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
 		Ptp4a3tm1.1Geh/Ptp4a3tm1.1Geh involves: 129S1/Sv * 129X1/SvJ * C57BL/6J MGI:5473976


Genotype
MGI:5473976
hm1
Allelic
Composition		 Ptp4a3tm1.1Geh/Ptp4a3tm1.1Geh
Genetic
Background		 involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptp4a3tm1.1Geh mutation (0 available); any Ptp4a3 mutation (15 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
mortality/aging

neoplasm
decreased incidence of tumors by chemical induction ( J:194458 )
• in a model of colitis-associated colon cancer, mice treated with AOM and DDS develop fewer intestinal tumors at 12 weeks post-treatment compared with control mice
decreased tumor growth/size ( J:194458 )
• no increase in tumor size or number between 12 and 16 weeks in mice treated with AOM and DDS

growth/size/body
decreased body mass index ( J:194458 )
• at 6 weeks in male, but not female, mice
decreased body weight ( J:194458 )
• at 6 weeks in male, but not female, mice

homeostasis/metabolism
decreased incidence of tumors by chemical induction ( J:194458 )
• in a model of colitis-associated colon cancer, mice treated with AOM and DDS develop fewer intestinal tumors at 12 weeks post-treatment compared with control mice




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
04/30/2024
MGI 6.23 		The Jackson Laboratory